Compounds (I) are provided that act as potent antagonists of the CCR2 or CCR9 receptor. Animal testing demonstrates that these compounds are useful f or treating inflammation, a hallmark disease for CCR2 and CCR9. The compound s are generally aryl sulfonamide derivatives and are useful in pharmaceutica l compositions, methods for the treatment of CCR2 -mediated diseases, CCR9 - mediated diseases, as controls in assays for the identification of CCR2 anta gonists and as controls in assays for the identification of CCR9 antagonists .
申请公布号
CA2657776(A1)
申请公布日期
2008.01.24
申请号
CA20072657776
申请日期
2007.07.10
申请人
CHEMOCENTRYX, INC.
发明人
TAN, XUEFEI;SULLIVAN, EDWARD J.;PENNELL, ANDREW M.K.;THOMAS, WILLIAM D.;PUNNA, SREENIVAS;UNGASHE, SOLOMON;ZENG, YIBIN;HU, CHENG;MELIKIAN, ANITA;NOVACK, AARON;CHARVAT, TREVOR T.